Phase IV Study of Qsymia in Obese Patients

Conditions

• Obesity

Interventions

• DRUG: Qsymia 3.75Mg-23Mg Extended Release Capsule
• DRUG: Qsymia 7.5Mg-46Mg Extended Release Capsule
• DRUG: Qsymia 11.25Mg-69Mg Extended Release Capsule
• DRUG: Qsymia 15Mg-92Mg Extended Release Capsule
• DRUG: Placebo

Sponsor

Alvogen Korea